Kexing Biopharm Expands Global Presence with Sorafenib Generic Approvals in Egypt and Peru Kexing Biopharm has received approvals for its Sorafenib Tosylate Tablets generic in Egypt and Peru, boosting access to cancer treatment in these regions.

Kexing Biopharm Expands Global Presence with Sorafenib Generic Approvals in Egypt and Peru #China #Shenzhen #Kexing_Biopharm #Sorafenib #Tosylate_Tablets